{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:20:21Z","timestamp":1790911221098,"version":"4.1.0"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>As part of the innate immune system, the complement system plays a key role in defense against pathogens and in host cell homeostasis. This enzymatic cascade is rapidly triggered in the presence of activating surfaces. Physiologically, it is tightly regulated on host cells to avoid uncontrolled activation and self-damage. In cases of abnormal complement dysregulation\/overactivation, the endothelium is one of the primary targets. Complement has gained momentum as a research interest in the last decade because its dysregulation has been implicated in the pathophysiology of many human diseases. Thus, it appears to be a promising candidate for therapeutic intervention. However, detecting abnormal complement activation is challenging. In many pathological conditions, complement activation occurs locally in tissues. Standard routine exploration of the plasma concentration of the complement components shows values in the normal range. The available tests to demonstrate such dysregulation with diagnostic, prognostic, and therapeutic implications are limited. There is a real need to develop tools to demonstrate the implications of complement in diseases and to explore the complex interplay between complement activation and regulation on human cells. The analysis of complement deposits on cultured endothelial cells incubated with pathologic human serum holds promise as a reference assay. This <jats:italic>ex vivo<\/jats:italic> assay most closely resembles the physiological context. It has been used to explore complement activation from sera of patients with atypical hemolytic uremic syndrome, malignant hypertension, elevated liver enzymes low platelet syndrome, sickle cell disease, pre-eclampsia, and others. In some cases, it is used to adjust the therapeutic regimen with a complement-blocking drug. Nevertheless, an international standard is lacking, and the mechanism by which complement is activated in this assay is not fully understood. Moreover, primary cell culture remains difficult to perform, which probably explains why no standardized or commercialized assay has been proposed. Here, we review the diseases for which endothelial assays have been applied. We also compare this test with others currently available to explore complement overactivation. Finally, we discuss the unanswered questions and challenges to overcome for validating the assays as a tool in routine clinical practice.<\/jats:p>","DOI":"10.3389\/fimmu.2022.860689","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T07:38:30Z","timestamp":1649749110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside"],"prefix":"10.3389","volume":"13","author":[{"given":"Marie-Sophie","family":"Meuleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fremeaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubka T.","family":"Roumenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Chauvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2020.10.002","article-title":"Docked SARS CoV-2 Proteins Within the Cutaneous and Subcutaneous Microvasculature and Their Role in the Pathogenesis of Severe COVID-19","volume":"106","author":"Magro","year":"2020","journal-title":"Hum Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic Uraemic Syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal Nocturnal Hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","article-title":"Alternative Complement Pathway Assessment in Patients With Atypical HUS","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006091069","article-title":"Hemolytic Uremic Syndrome: A Factor H Mutation (E1172Stop) Causes Defective Complement Control at the Surface of Endothelial Cells","volume":"18","author":"Heinen","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and Homozygous Factor H Deficiencies Associated With Hemolytic Uremic Syndrome or Membranoproliferative Glomerulonephritis: Report and Genetic Analysis of 16 Cases","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M900814200","article-title":"Mutations of Factor H Impair Regulation of Surface-Bound C3b by Three Mechanisms in Atypical Hemolytic Uremic Syndrome","volume":"284","author":"Lehtinen","year":"2009","journal-title":"J Biol Chem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16651","article-title":"Mutations in Factor H Reduce Binding Affinity to C3b and Heparin and Surface Attachment to Endothelial Cells in Hemolytic Uremic Syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molimm.2007.05.004","article-title":"Characterization of Mutations in Complement Factor I (CFI) Associated With Hemolytic Uremic Syndrome","volume":"45","author":"Kavanagh","year":"2008","journal-title":"Mol Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in Components of Complement Influence the Outcome of Factor I-Associated Atypical Hemolytic Uremic Syndrome","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and Functional Analyses of Membrane Cofactor Protein (CD46) Mutations in Atypical Hemolytic Uremic Syndrome","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004050380","article-title":"Anti\u2013Factor H Autoantibodies Associated With Atypical Hemolytic Uremic Syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402770","article-title":"Anti\u2013Factor H Autoantibodies in C3 Glomerulopathies and in Atypical Hemolytic Uremic Syndrome: One Target, Two Diseases","volume":"194","author":"Blanc","year":"2015","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016030343","article-title":"Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative Gn","volume":"28","author":"Marinozzi","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2016.01.010","article-title":"Complement Gene Variants Determine the Risk of Immunoglobulin-Associated MPGN and C3 Glomerulopathy and Predict Long-Term Renal Outcome","volume":"71","author":"Iatropoulos","year":"2016","journal-title":"Mol Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250529","article-title":"Hepatitis C Virus-Related Proteins in Kidney Tissue From Hepatitis C Virus-Infected Patients With Cryoglobulinemic Membranoproliferative Glomerulonephritis","volume":"25","author":"Sansonno","year":"1997","journal-title":"Hepatology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.212","article-title":"The Role of Complement in Antibody-Mediated Rejection in Kidney Transplantation","volume":"8","author":"Stegall","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.6.4101","article-title":"Pathogenic Complement Activation in Collagen Antibody- Induced Arthritis in Mice Requires Amplification by the Alternative Pathway","volume":"179","author":"Banda","year":"2007","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.3.1904","article-title":"Alternative Complement Pathway Activation Is Essential for Inflammation and Joint Destruction in the Passive Transfer Model of Collagen-Induced Arthritis","volume":"177","author":"Banda","year":"2006","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.2.786","article-title":"Modulation of Renal Disease in MRL\/ Lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B","volume":"164","author":"Watanabe","year":"2000","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00371.x","article-title":"Effects of Complement Factor D Deficiency on the Renal Disease of MRL\/lpr Mice","volume":"65","author":"Elliott","year":"2004","journal-title":"Kidney Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.30222","article-title":"The Benefit of Targeted and Selective Inhibition of the Alternative Complement Pathway for Modulating Autoimmunity and Renal Disease in MRL\/lpr Mice","volume":"63","author":"Sekine","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R","article-title":"Direct Binding of C1q to Apoptotic Cells and Cell Blebs Induces Complement Activation","volume":"32","author":"Nauta","year":"2002","journal-title":"Eur J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.09.018","article-title":"Short Leucine-Rich Glycoproteins of the Extracellular Matrix Display Diverse Patterns of Complement Interaction and Activation","volume":"46","author":"Sj\u00f6berg","year":"2009","journal-title":"Mol Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1989.tb01199.x","article-title":"Complement-Fixing Properties of Human IgA Antibodies Alternative Pathway Complement Activation by Plastic-Bound, But Not Specific Antigen-Bound, IgA","volume":"30","author":"Russell","year":"1989","journal-title":"Scand J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nephro.2014.07.347","article-title":"L\u2019analyse Prot\u00e9omique De Complexes Immuns Artificiels IgA1-IgG R\u00e9v\u00e8le Une Association Avec Des Formes Activ\u00e9es De C3","volume":"10","author":"Maillard","year":"2014","journal-title":"N\u00e9phrologie Th\u00e9rapeutique"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1708247114","article-title":"Necroptosis Controls NET Generation and Mediates Complement Activation, Endothelial Damage, and Autoimmune Vasculitis","volume":"114","author":"Schreiber","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25742","article-title":"Complement Activation in Sickle Cell Disease: Dependence on Cell Density, Hemolysis and Modulation by Hydroxyurea Therapy","volume":"95","author":"Roumenina","year":"2020","journal-title":"Am J Hematol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-489245","article-title":"Complement Activation by Heme as a Secondary Hit for Atypical Hemolytic Uremic Syndrome","volume":"122","author":"Frimat","year":"2013","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.09.033","article-title":"Complement Activation is a Crucial Driver of Acute Kidney Injury in Rhabdomyolysis","volume":"99","author":"Boudhabhay","year":"2020","journal-title":"Kidney Int"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A Novel C5a Receptor-Tissue Factor Cross-Talk in Neutrophils Links Innate Immunity to Coagulation Pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70053-0","article-title":"Hepatitis C Virus, Cryoglobulinaemia, and Vasculitis: Immune Complex Relations","volume":"5","author":"Sansonno","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-Mediated Rejection of Solid-Organ Allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408835103","article-title":"Drusen Complement Components C3a and C5a Promote Choroidal Neovascularization","volume":"103","author":"Nozaki","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q Deficiency Causes Glomerulonephritis Associated With Multiple Apoptotic Bodies","volume":"19","author":"Botto","year":"1998","journal-title":"Nat Genet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.09.018","article-title":"C5a Receptor 1 Promotes Autoimmunity, Neutrophil Dysfunction and Injury in Experimental Anti-Myeloperoxidase Glomerulonephritis","volume":"93","author":"Dick","year":"2018","journal-title":"Kidney Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008050497","article-title":"C5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-283564","article-title":"Complement Alternative Pathway Acts as a Positive Feedback Amplification of Neutrophil Activation","volume":"117","author":"Camous","year":"2011","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117430","article-title":"C5a-Induced Expression of P-Selectin in Endothelial Cells","volume":"94","author":"Foreman","year":"1994","journal-title":"J Clin Invest"},{"key":"B41","article-title":"Interaction of the Terminal Complement Components C5b-9 With Synovial Fibroblasts: Binding to the Membrane Surface Leads to Increased Levels in Collagenase-Specific mRNA","volume":"78","author":"Jahn","year":"1993","journal-title":"Immunology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/jcp.21129","article-title":"Complement 3 is Involved in Changing the Phenotype of Human Glomerular Mesangial Cells","volume":"213","author":"Wan","year":"2007","journal-title":"J Cell Physiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13466","article-title":"Complement 5a-Mediated Trophoblasts Dysfunction is Involved in the Development of Pre-Eclampsia","volume":"22","author":"Ma","year":"2017","journal-title":"J Cell Mol Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02237","article-title":"Interpretation of Serological Complement Biomarkers in Disease","volume":"9","author":"Ekdahl","year":"2018","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/cei.13497","article-title":"MASP2 Levels Are Elevated in Thrombotic Microangiopathies: Association With Microvascular Endothelial Cell Injury and Suppression by Anti-MASP2 Antibody Narsoplimab","volume":"203","author":"Elhadad","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-3083.1985.tb01871.x","article-title":"Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme-Linked Immunosorbent Assay Based on Monoclonal Antibodies Against a Neoantigen of the Complex","volume":"22","author":"Mollnes","year":"1985","journal-title":"Scand J Immunol"},{"key":"B47","article-title":"On the Destruction of Erythrocytes and Other Cells by Antibody and Complement","volume":"21","author":"Mayer","year":"1961","journal-title":"Cancer Res"},{"key":"B48","article-title":"Activation of the Alternate Pathway of Human Complements by Rabbit Cells","volume":"113","author":"Platts-Mills","year":"1974","journal-title":"J Immunol Baltim Md 1950"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/41.4.586","article-title":"Automated Homogeneous Liposome-Based Assay System for Total Complement Activity","volume":"41","author":"Yamamoto","year":"1995","journal-title":"Clin Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2004.11.016","article-title":"Functional Analysis of the Classical, Alternative, and MBL Pathways of the Complement System: Standardization and Validation of a Simple ELISA","volume":"296","author":"Seelen","year":"2005","journal-title":"J Immunol Methods"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.01.003","article-title":"Functional Analysis in Serum From Atypical Hemolytic Uremic Syndrome Patients Reveals Impaired Protection of Host Cells Associated With Mutations in Factor H","volume":"41","author":"Sanchezcorral","year":"2004","journal-title":"Mol Immunol"},{"key":"B52","first-page":"1","article-title":"C3 Nephritic Factor (C3NeF): Stabilization of Fluid Phase and Cell-Bound Alternative Pathway Convertase","volume":"116","author":"Daha","year":"1976","journal-title":"J Immunol Baltim Md 1950"},{"key":"B53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-3801-8_1","article-title":"\u201cMethods of Immunohistochemistry and Immunofluorescence: Converting Invisible to Visible.,\u201d","volume-title":"The Tumor Microenvironment","author":"Mori","year":"2016"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000000234","article-title":"Role of the Skin Biopsy in the Diagnosis of Atypical Hemolytic Uremic Syndrome","volume":"37","author":"Magro","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"B55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-319-57613-8_4","article-title":"\u201cEndothelial Cells\u201d","volume-title":"The Immunology of Cardiovascular Homeostasis and Pathology","author":"Sturtzel","year":"2017"},{"key":"B56","doi-asserted-by":"publisher","first-page":"a006429","DOI":"10.1101\/cshperspect.a006429","article-title":"Endothelial Cell Heterogeneity","volume":"2","author":"Aird","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00411-9","article-title":"Phenotypic Diversity and Metabolic Specialization of Renal Endothelial Cells","volume":"17","author":"Dumas","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1434429100","article-title":"Endothelial Cell Diversity Revealed by Global Expression Profiling","volume":"100","author":"Chi","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e51413","DOI":"10.7554\/eLife.51413","article-title":"Endothelial Heterogeneity Across Distinct Vascular Beds During Homeostasis and Inflammation","volume":"9","author":"Jambusaria","year":"2020","journal-title":"eLife"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12479","article-title":"Endothelial Cells: Source, Barrier, and Target of Defensive Mediators","volume":"274","author":"Roumenina","year":"2016","journal-title":"Immunol Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.002639","article-title":"Brain Microvascular Endothelial Cells Exhibit Lower Activation of the Alternative Complement Pathway Than Glomerular Microvascular Endothelial Cells","volume":"293","author":"Sartain","year":"2018","journal-title":"J Biol Chem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500960","article-title":"TNF Regulates Essential Alternative Complement Pathway Components and Impairs Activation of Protein C in Human Glomerular Endothelial Cells","volume":"196","author":"Sartain","year":"2016","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(97)04737-X","article-title":"TNF-\u03b1 Stimulates the Biosynthesis of Complement C3 and Factor B by Human Umbilical Cord Vein Endothelial Cells","volume":"116","author":"Kawakami","year":"1997","journal-title":"Cancer Lett"},{"key":"B64","article-title":"Differential Regulation of Complement Factor H and C3 Production in Human Umbilical Vein Endothelial Cells by IFN-Gamma and IL-1","volume":"144","author":"Brooimans","year":"1990","journal-title":"J Immunol Baltim Md 1950"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1042\/bj2810437","article-title":"Effect of Interferon-\u03b3 on Complement Gene Expression in Different Cell Types","volume":"281","author":"Lappin","year":"1992","journal-title":"Biochem J"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03008","article-title":"Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1","volume":"9","author":"May","year":"2018","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12613748","article-title":"HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line","volume":"99","author":"Ades","year":"1992","journal-title":"J Invest Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000277","article-title":"Conditionally Immortalized Human Glomerular Endothelial Cells Expressing Fenestrations in Response to VEGF","volume":"69","author":"Satchell","year":"2006","journal-title":"Kidney Int"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.12.3734","article-title":"Permanent Cell Line Expressing Human Factor VIII-Related Antigen Established by Hybridization","volume":"80","author":"Edgell","year":"1983","journal-title":"Proc Natl Acad Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-629683","article-title":"Modified Ham Test for Atypical Hemolytic Uremic Syndrome","volume":"125","author":"Gavriilaki","year":"2015","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04674.x","article-title":"Complement Activation in Thrombotic Thrombocytopenic Purpura","volume":"10","author":"R\u00e9ti","year":"2012","journal-title":"J Thromb Haemost JTH"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601121","article-title":"Interaction Between Multimeric Von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis","volume":"199","author":"Bettoni","year":"2017","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.4.1224","article-title":"Thrombotic Thrombocytopenic Purpura and Sporadic Hemolytic-Uremic Syndrome Plasmas Induce Apoptosis in Restricted Lineages of Human Microvascular Endothelial Cells","volume":"89","author":"Mitra","year":"1997","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107470","article-title":"Culture of Human Endothelial Cells Derived From Umbilical Veins. Identification By Morphologic And Immunologic Criteria","volume":"52","author":"Jaffe","year":"1973","journal-title":"J Clin Invest"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2004.00254.x","article-title":"A Method for the Isolation of Glomerular and Tubulointerstitial Endothelial Cells and a Comparison of Characteristics With the Human Umbilical Vein Endothelial Cell Model","volume":"9","author":"Mcginn","year":"2004","journal-title":"Nephrology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.170","article-title":"Effects of Tnf\u03b1 on Verocytotoxin Cytotoxicity in Purified Human Glomerular Microvascular Endothelial Cells","volume":"51","author":"van Setten","year":"1997","journal-title":"Kidney Int"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2012.093","article-title":"Establishment of Outgrowth Endothelial Cells From Peripheral Blood","volume":"7","author":"Martin-Ramirez","year":"2012","journal-title":"Nat Protoc"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-197640","article-title":"Hyperfunctional C3 Convertase Leads to Complement Deposition on Endothelial Cells and Contributes to Atypical Hemolytic Uremic Syndrome","volume":"114","author":"Roumenina","year":"2009","journal-title":"Blood"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-383281","article-title":"A Prevalent C3 Mutation in aHUS Patients Causes a Direct C3 Convertase Gain of Function","volume":"119","author":"Roumenina","year":"2012","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013070796","article-title":"Complement Factor B Mutations in Atypical Hemolytic Uremic Syndrome\u2014Disease-Relevant or Benign","volume":"25","author":"Marinozzi","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-609073","article-title":"Mapping Interactions Between Complement C3 and Regulators Using Mutations in Atypical Hemolytic Uremic Syndrome","volume":"125","author":"Schramm","year":"2015","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of Complement Activation in aHUS and How to Monitor Eculizumab Therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013121339","article-title":"A Novel Atypical Hemolytic Uremic Syndrome\u2013Associated Hybrid CFHR1\/CFH Gene Encoding a Fusion Protein That Antagonizes Factor H\u2013Dependent Complement Regulation","volume":"26","author":"Valoti","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.03.039","article-title":"Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti\u2013Factor H Iga\u03bb Antibody","volume":"66","author":"Rigothier","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ajkd.2018.11.012","article-title":"An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome","volume":"74","author":"Galbusera","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4174-1","article-title":"Hemolytic Uremic Syndrome Associated With Bordetella Pertussis Infection in a 2-Month-Old Infant Carrying a Pathogenic Variant in Complement Factor H","volume":"34","author":"Madden","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005246","article-title":"C5a and C5aR1 are Key Drivers of Microvascular Platelet Aggregation in Clinical Entities Spanning From aHUS to COVID-19","volume":"6","author":"Aiello","year":"2021","journal-title":"Blood Adv"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.579418","article-title":"Molecular Studies and an Ex Vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant","volume":"7","author":"Piras","year":"2020","journal-title":"Front Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018020184","article-title":"C5b9 Formation on Endothelial Cells Reflects Complement Defects Among Patients With Renal Thrombotic Microangiopathy and Severe Hypertension","volume":"29","author":"Timmermans","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16796","article-title":"Complement as the Enabler of Carfilzomib-Induced Thrombotic Microangiopathy","volume":"193","author":"Blasco","year":"2020","journal-title":"Br J Haematol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05830519","article-title":"Complement Activation and Thrombotic Microangiopathies","volume":"14","author":"Palomo","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015040348","article-title":"A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H","volume":"27","author":"Chauvet","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.647008","article-title":"Functional Characterization of Autoantibodies Against Complement Component C3 in Patients With Lupus Nephritis","volume":"290","author":"Vasilev","year":"2015","journal-title":"J Biol Chem"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13443","article-title":"Clinical and Functional Consequences of Anti-Properdin Autoantibodies in Patients With Lupus Nephritis","volume":"201","author":"Radanova","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003863","article-title":"Complement Activity and Complement Regulatory Gene Mutations are Associated With Thrombosis in APS and CAPS","volume":"135","author":"Chaturvedi","year":"2020","journal-title":"Blood"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005171","article-title":"More About Complement in the Antiphospholipid Syndrome","volume":"136","author":"Timmermans","year":"2020","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01460","article-title":"Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2020.06.002","article-title":"Hyperhemolytic Transfusion Reaction in Non-Hemoglobinopathy Patients and Terminal Complement Pathway Activation: Case Series and Review of the Literature","volume":"34","author":"Cid","year":"2020","journal-title":"Transfus Med Rev"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1814797116","article-title":"P-Selectin Drives Complement Attack on Endothelium During Intravascular Hemolysis in TLR-4\/Heme-Dependent Manner","volume":"116","author":"Merle","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"B100","article-title":"Effect of Time, Temperature and Anticoagulants on In Vitro Complement Activation: Consequences for Collection and Preservation of Samples to be Examined for Complement Activation","volume":"73","author":"Mollnes","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e96910","DOI":"10.1172\/jci.insight.96910","article-title":"Intravascular Hemolysis Activates Complement via Cell-Free Heme and Heme-Loaded Microvesicles","volume":"3","author":"Merle","year":"2018","journal-title":"JCI Insight"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041497","article-title":"Platelet Activation Leads to Activation and Propagation of the Complement System","volume":"201","author":"del Conde","year":"2005","journal-title":"J Exp Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.03.023","article-title":"Von Willebrand Factor Regulates Complement on Endothelial Cells","volume":"90","author":"Noone","year":"2016","journal-title":"Kidney Int"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/s41598-021-82733-z","article-title":"Complement and Coagulation Cascades Activation Is the Main Pathophysiological Pathway in Early-Onset Severe Preeclampsia Revealed by Maternal Proteomics","volume":"11","author":"Youssef","year":"2021","journal-title":"Sci Rep"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13714","article-title":"Diagnostic and Risk Factors for Complement Defects in Hypertensive Emergency and Thrombotic Microangiopathy","volume":"75","author":"Timmermans","year":"2020","journal-title":"Hypertension"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.05.018","article-title":"Sensitive, Reliable and Easy-Performed Laboratory Monitoring of Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome","volume":"160","author":"Volokhina","year":"2015","journal-title":"Clin Immunol Orlando Fla"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-770214","article-title":"Eculizumab Cessation in Atypical Hemolytic Uremic Syndrome","volume":"130","author":"Merrill","year":"2017","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0031-6","article-title":"Clinical Promise of Next-Generation Complement Therapeutics","volume":"18","author":"Mastellos","year":"2019","journal-title":"Nat Rev Drug Discov"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.860689\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T07:38:42Z","timestamp":1649749122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.860689\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":109,"alternative-id":["10.3389\/fimmu.2022.860689"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.860689","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"article-number":"860689"}}